CERVICAL HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION
Clinical trials for CERVICAL HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION explained in plain language.
Never miss a new study
Get alerted when new CERVICAL HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION trials appear
Sign up with your email to follow new studies for CERVICAL HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental shot aims to reverse HPV-Linked cervical precancer
Disease control Not yet recruitingThis study tests an experimental biologic, NWRD09, in women aged 18 to 65 with HPV16-positive cervical high-grade squamous intraepithelial lesions (HSIL), a precancerous condition. Participants receive four intramuscular injections over 12 weeks. The main goal is to see if the tr…
Matched conditions: CERVICAL HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION
Phase: PHASE2 • Sponsor: Newish Biotech (Wuxi) Co., Ltd. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New shot aims to boost immunity against HPV in HIV patients
Disease control Not yet recruitingThis study tests an immunotherapy called PDS0101 in 27 adults with both HIV and HPV 16. The goal is to see if it is safe and can strengthen the immune system's response against HPV, which can cause cancers like anal and cervical cancer. All participants will receive three doses o…
Matched conditions: CERVICAL HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC